Study Protocol
Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell carcinoma: study protocol of a randomized, multicenter, double blind, phase II trial (NATION-2203 trial)
Jun Yin, Siyun Lin, Yong Fang, Heng Jiao, Zongwei Chen, Han Tang, Jianmin Gu, Shaoyuan Zhang, Linyi Sun, Yin Li, Yongtao Han, Qixun Chen, Haiquan Chen, Zhigang Li, Lijie Tan
